Average Co-Inventor Count = 4.17
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (17 from 212 patents)
2. Merck Frosst Canada & Co. (7 from 76 patents)
3. Merck + Co., Inc. (3 from 4,770 patents)
4. Other (1 from 832,680 patents)
5. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
28 patents:
1. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors
2. 6743802 - Alkyne-aryl phosphodiesterase-4 inhibitors
3. 6677351 - 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
4. 6399636 - Tri-aryl-substituted-ethane PDE4 inhibitors
5. 6200993 - Heterosubstituted pyridine derivatives as PDE4 inhibitors
6. 6180650 - Heterosubstituted pyridine derivatives as PDE 4 inhibitors
7. 6057319 - 3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
8. 5710170 - Tri-aryl ethane derivatives as PDE IV inhibitors
9. 5698584 - 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors
10. 5639780 - N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase
11. 5604253 - N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase
12. 5576338 - Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis
13. 5428060 - Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
14. 5426109 - Phenylnaphthalene hydroxy acids
15. 5350744 - Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis